Table 2.
Clinicopathological characteristics of 15 patients with advanced HCC treated with TACE.
| Patient ID | Age | HCV/cirrhosis | Presentation | AFP (ng/mL) | Grade | TNM stage | Child-Pugh class | OKUDA stage | CLIP | Response score |
|---|---|---|---|---|---|---|---|---|---|---|
| Responders | ||||||||||
| P1 | 49.00 | +/+ | Jaundice | 16.00 | 2.00 | T1 | B | 2 | 3 | 1.00 |
| P2 | 42.00 | ND | Pain | 3.00 | 2.00 | T1 | B | ND | 1 | 1.00 |
| P3 | 52.00 | ND | Pain | 969.00 | ND | T3b | B | 2 | 4 | 1.00 |
| P4 | 52.00 | +/− | ND | 107000 | 3.00 | T1 | B | 2 | 4 | 2.00 |
| P5 | 50.00 | −/+ | ND | 342.00 | 3.00 | T1 | B | ND | 1 | 2.00 |
|
| ||||||||||
| Nonresponders | ||||||||||
| P6 | 43.00 | ND | Pain | 276.00 | 2.00 | T2 | ND | 2 | 1 | 4.00 |
| P7 | 57.00 | −/+ | ND | 4.00 | 2.00 | T1 | B | 1 | 1 | 3.00 |
| P8 | 59.00 | −/+ | Pain | ND | 2.00 | T2 | A | 2 | 2 | 4.00 |
| P9 | 57.00 | −/+ | ND | 28.00 | ND | T2 | B | 2 | 2 | 3.00 |
| P10 | 52.00 | ND | Pain | 90.00 | 1.00 | T3a | B | 2 | 3 | 4.00 |
| P11 | 61.00 | ND | Ascites | 350.00 | 2.00 | T2 | B | 2 | 2 | 5.00 |
| P12 | 58.00 | −/+ | ND | 2580.00 | ND | T3a | B | 2 | 4 | 5.00 |
| P13 | 67.00 | ND | Recurrence | 978.00 | 2.00 | T3a | A | 2 | 3 | 3.00 |
| P14 | 56.00 | +/+ | ND | ND | 2.00 | T1 | A | 1 | 0 | 3.00 |
| P15 | 58.00 | −/+ | Pain | 10.00 | 2.00 | T2 | B | 2 | 3 | 4.00 |
TNM: tumor, node, and metastases; AFP: alpha-fetoprotein; ND: not defined; CLIP: Cancer of the Liver Italian Program.